Philips Receives FDA Clearance for Rembra CT Platform
Clearances for Rembra CT, Rembra RT, and Areta RT aim to enable high-throughput imaging at scale and elevate precision across the cancer care pathway.
Clearances for Rembra CT, Rembra RT, and Areta RT aim to enable high-throughput imaging at scale and elevate precision across the cancer care pathway.
The platform combines planning, navigation, and robotics, with AI-enabled features for imaging and workflow support.
The CTA-based system creates a patient-specific 3D map of the cardiac conduction system to support planning and guidance during procedures such as TAVR and conduction system pacing.
Clearances for Rembra CT, Rembra RT, and Areta RT aim to enable high-throughput imaging at scale and elevate precision across the cancer care pathway.
Elekta’s Evo system combines CT-guided radiation therapy with AI-enhanced imaging designed to support visualization of tumors and nearby organs at risk during treatment.
Read MoreThe system integrates depth imaging technology directly into biopsy tools to improve tissue sampling accuracy during bronchoscopy.
Read MoreThe newly cleared system is designed to support breast biopsy procedures across multiple imaging modalities using a single platform.
Read MoreThe system is designed to give surgeons a clear, real-time view of critical anatomy and planned trajectories.Â
Read MoreThe clearance enables on-premise AI analysis of coronary CT angiography for quantifying calcified and non-calcified plaque.
Read MoreThe vendor-agnostic system enables remote scanning in a command center configuration and real-time remote expertise.
Read More
The software, powered by artificial intelligence and deep learning, assesses angiography-derived coronary physiology in patients with ischemic coronary artery disease.